Cj. Gurusinghe et al., INHIBIN AND ACTIVIN ARE DEMONSTRABLE BY IMMUNOHISTOCHEMISTRY IN OVARIAN TUMOR-TISSUE, Gynecologic oncology, 57(1), 1995, pp. 27-32
Elevated serum immunoreactive inhibin concentrations have been reporte
d in patients with mucinous and granulosa cell tumors of the ovary, Th
e present study aimed to determine whether the inhibins and/or the rel
ated peptides, the activins, were demonstrable within ovarian tumor ti
ssue. Immunohistochemical analyses were performed on 11 ovarian tumors
, 5 mucinous, 3 serous, 1 granulosa, 1 clear cell, and 1 metastatic co
lonic cancer, Both monoclonal and polyclonal antisera specific for inh
ibin-A, activin-a, and activin-B, and their alpha-, beta(A)-, and beta
(B)-subunits were used. The mucinous cells of all five mucinous tumors
showed positive staining for activin-A and activin-B, and their beta(
A)- and beta(B)-subunits, and three stained positive for inhibin-A and
the alpha -subunit. The granulosa cell tumor also showed positive sta
ining for inhibin-A and the activins. The remaining tumors were negati
ve. The findings are consistent with the hypersecretion of inhibin (an
d possibly activin) by some ovarian malignancies and suggest that immu
nohistochemistry for the inhibins and the activins should be explored
further in the classification of ovarian malignancies. (C) 1995 Academ
ic Press, Inc.